For the quarter ending 2025-12-31, ELMD had -$322K decrease in cash & cash equivalents over the period. $2,392K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Impairment of intangible assets | - | - | 212 |
| Net income | 2,761 | 2,136 | 7,537 |
| Depreciation | 213 | 214 | 1,039 |
| Deferred income taxes | - | - | -310 |
| Amortization | 45 | 45 | 133 |
| Share-based compensation expense | 656 | 458 | 3,059 |
| Accounts receivable | 1,504 | 96 | 1,327 |
| Contract assets | -18 | 134 | 317 |
| Inventories | -255 | 515 | -175 |
| Prepaid expenses and other assets | 450 | 241 | 959 |
| Income tax payable, net | 588 | 202 | -685 |
| Accounts payable and accrued liabilities | -536 | 448 | 1,650 |
| Accrued compensation | 980 | -2,348 | 1,186 |
| Net cash provided by operating activities | 3,026 | 169 | 11,393 |
| Expenditures for property and equipment | 634 | 252 | 262 |
| Expenditures for finite-life intangible assets | 22 | 15 | 44 |
| Net cash used for investing activities | -656 | -267 | -306 |
| Issuance of common stock upon exercise of options | 76 | 156 | 398 |
| Taxes paid on net share settlement of stock awards | 5 | 229 | 2,278 |
| Repurchase of common stock | 2,763 | 1,003 | 10,000 |
| Net cash used for financing activities | -2,692 | -1,076 | -11,880 |
| Net (decrease) increase in cash | -322 | -1,174 | -793 |
| Cash and cash equivalents at beginning of period | 14,113 | 15,287 | - |
| Cash and cash equivalents at end of period | 13,791 | 14,113 | - |
Electromed, Inc. (ELMD)
Electromed, Inc. (ELMD)